Pharmaceutics, Drug Delivery and Pharmaceutical TechnologyA Spray-dried Combination of CAPREOMYCIN (cas 11003-38-6) and CPZEN-45 for Inhaled Tuberculosis Therapy

Add time:08/16/2019    Source:sciencedirect.com

Tuberculosis (TB) remains the single most serious infectious disease attributable to a single-causative organism. A variety of drugs have been evaluated for pulmonary delivery as dry powders: CAPREOMYCIN (cas 11003-38-6) sulfate has shown efficacy and was safely delivered by inhalation at high doses to human volunteers, whereas CPZEN-45 is a new drug that has also been shown to kill resistant TB. The studies here combine these drugs—acting by different mechanisms—as components of single particles by spray-drying, yielding a new combination drug therapy. The spray-dried combination powder was prepared in an aerodynamic particle size range suitable for pulmonary delivery. Physicochemical storage stability was demonstrated for a period of 6 months. The spray-dried combination powders of capreomycin and CPZEN-45 have only moderate affinity for mucin, indicating that delivered drug will not be bound by these mucins in the lung and available for microbicidal effects. The pharmacokinetics of disposition in guinea pigs demonstrated high local concentrations of drug following direct administration to the lungs and subsequent systemic bioavailability. Further studies are required to demonstrate the in vivo efficacy of the combination to confirm the therapeutic potential of this novel combination.

We also recommend Trading Suppliers and Manufacturers of CAPREOMYCIN (cas 11003-38-6). Pls Click Website Link as below: cas 11003-38-6 suppliers

Prev:Synergistic activities of clofazimine with moxifloxacin or CAPREOMYCIN (cas 11003-38-6) against Mycobacterium tuberculosis in China
Next:Assessing CAPREOMYCIN (cas 11003-38-6) resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis)